Lotte Biologics CEO James Park discusses the Alvotech agreement, U.S. manufacturing, Songdo expansion and the company's ...
This week on "The Friday Brief," plenty of partnerships dotted the headlines, but acquisitions made some news as well.
Manish Jain, President, Cilicant, shares insight on industry trends, particularly in active packaging solutions.
Earlier alignment on trial design, evidence generation and geography can help emerging biopharma companies navigate ...
Stage-appropriate development can help lean biotech teams preserve capital, manage risk and maintain momentum without closing ...
Technology transfer creates plenty of documentation. Process descriptions, risk assessments, batch records, specifications, ...
Mike Stenberg, VP, Business Development, LGM Pharma, discusses LGM's strategic expansion, lessons learned from previous ...
Agile CDMO partnerships can preserve scientific knowledge, reduce handoff risk and help programs move more smoothly from ...
Diversifying API sourcing and building qualified alternatives can help manufacturers reduce exposure to geographic ...
Understanding a CDMOs operating model under uncertainty can help determine whether it is the right partner for the program.
How early risk identification, standardized processes and digital technologies can help sponsors streamline technology ...
For high-dose, high-concentration biologics, early alignment preserves flexibility, exposes risks before they become expensive and avoids constraints in manufacturing, clinical de ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results